GlassScriptPhysician profile
Jeffrey Wilson
NPI 1003287079
$31,154.67
in general payments reported to CMS, 2019-2025
24 companies · $2,546 in 2025
The $2,546 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,576 · 2020: $3,641 · 2021: $1,517 · 2022: $5,976 · 2023: $1,807 · 2024: $12K · 2025: $2,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,771 · Food and Beverage: $4,252 · Travel and Lodging: $2,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,770.90 |
| Food and Beverage | $4,251.50 |
| Travel and Lodging | $2,422.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $12,247.66 | 2020-2024 | |
| Medtronic, INC. | $6,326.48 | 2021-2025 | Micra, In.Pact Admiral, Onyx Frontier |
| Abbott Laboratories | $4,753.76 | 2019-2025 | Diamondback Peripheral, Optis, Supera |
| Boston Scientific Corporation | $1,868.90 | 2019-2025 | Avvigo Guidance System, Opticross, General - Ultrasound |
| Medtronic Vascular, INC. | $1,785.55 | 2019-2020 | |
| Edwards Lifesciences Corporation | $925.73 | 2020 | |
| Abiomed | $712.12 | 2023-2025 | Impella |
| Irhythm Technologies, INC. | $422.49 | 2022 | |
| Shockwave Medical, INC | $354.01 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astellas Pharma US INC | $289.93 | 2019 | |
| Stryker Corporation | $245.43 | 2025 | Clottriever Bold Catheter |
| Philips North America LLC | $212.22 | 2022-2025 | (Bk5) Azurion 5 M20, Azurion 7 B20 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $195.38 | 2019-2021 | |
| Asahi Intecc USA, INC. | $190.63 | 2022-2023 | Asahi Ptca Guide Wire |
| E.R. Squibb & Sons, L.L.C. | $173.23 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $114.92 | 2019-2022 | |
| Cardiovascular Systems INC. | $84.17 | 2021 | |
| Novartis Pharmaceuticals Corporation | $32.52 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $24.84 | 2024 | |
| Amgen INC. | $22.46 | 2021 | |
| Novo Nordisk INC | $18.94 | 2024 | Wegovy |
| Pfizer INC. | $16.88 | 2022 | |
| Chiesi USA, INC. | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.